USPTO serial 76188450
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Chuo-ku, Tokyo, JP
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David Toren
KATRIN LEWERTOFF SIDLEY AUSTIN LLP787 7TH AVENEW YORK, NY 10019UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, agents affecting the central nervous system, the peripheral nervous system, sensory organs, respiratory organs and digestive organs; antiallergic agents; cardiovascular agents; hormones for medical purposes; urogenital and anal treatment agents; dermatological preparations; vitamins; nutritional supplements and dietary supplements containing amino acid preparations for medical use; nutritional supplements and dietary supplements containing calcium; nutritional supplements and dietary supplements containing chondroitin preparations; nutritional supplements and dietary supplements containing food enriching preparations; nutritional supplements and dietary supplements containing organotherapy preparations proteins, amino acids and their preparations, saccharide preparations, mineral preparations, medical alcohol beverages and organic preparations; agents for blood, namely anticoagulants, blood substitutes, blood-plasma and hemostatics; pharmaceutical preparations for treatment of metabolic conditions; tumor suppressing agents; agents for treating physically caused skin lesions; agents for treating chemically caused skin lesions; antibiotic preparations; chemotherapeutic agents; parasiticides for domestic, agricultural and medical use; diagnostic reagents for medical laboratory use; veterinary preparations namely agents affecting the central nervous systems, the peripheral nervous system and the digestive organs, cardiovascular agents; hormones for medical purposes; vitamins; veterinary preparations for treatment of metabolic conditions; antibiotic preparations, biological preparations, namely clinical reagents for medical purposes; mosquito-repellent incenses; general purpose germicides; fungicides, insecticides, pesticides; fumigants and herbicides all for agricultural and domestic use; room deodorants not for personal use; insect repellents; mothproofing preparations, namely moth balls; antiseptics | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 6, 2006 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 14, 2003 | PETD | PETITION TO REVIVE-DENIED | — |
| May 12, 2003 | PETR | PETITION TO REVIVE-RECEIVED | — |
| May 12, 2003 | PAPER RECEIVED | — | |
| Nov 4, 2002 | ABN0 | ABANDONMENT - INCOMPLETE RESPONSE | — |
| Sep 25, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 25, 2002 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2002 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 9, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 23, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 12, 2001 | DOCK | ASSIGNED TO EXAMINER | — |